Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$123.2M
2 rounds on record
Latest round
$61.6M
Venture round · Jun 2020 · 6 yr ago
Team
17
US Form 5500 (plan participants) · Dec 2024
Backers
2
Lightstone Ventures, venBio Partners
The money's age
Long since its last round
75 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jun 2020 $61.6M — SEC Form D
Venture round Jun 2020 $61.6M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Tallac Therapeutics, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Hong WanExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

People

Hong Wan
Executive Officer, Director
Christine Brennan
Director
Isaac Cheng
Director
Corey Goodman
Director
Jaume Pons
Director
Michael Carusi
Director
Ran Geng
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Burlingame United States
HQ
200-500 est. staff

Financials

Total raised
$123.2M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2020 $61.6M Details
Venture - Series Unknown 2020 $61.6M Details